This issue brief explores the provisions of health coverage and cost-sharing for primary care and prescription drugs in Denmark, England, France, Germany, the Netherlands, and Sweden and draws lessons for policy reform and insurance design in the United States. Although none of the six countries spends more than 11 percent of gross domestic product on health care—compared with 16.2 percent in the United States—they are able to provide a level of access to and financial protection for primary care and prescription drugs that far exceeds what is available in this country.